Guorui Xie

Guorui (Grace) Xie is a Senior Scientist specializing in Biomarker/Translational Immunology at HI-Bio, a Biogen Company, since October 2024. Prior to this role, Guorui Xie held positions as Scientist II and Scientist I at RAPT Therapeutics from August 2021 to July 2024. Guorui Xie also completed a postdoctoral fellowship at Gladstone Institutes from November 2015 to August 2021. Guorui Xie earned a PhD in Immune response to West Nile virus infection from The University of Texas Medical Branch in 2015, following a bachelor's degree from Shandong Normal University in 2007.